Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,087) with videos related to
Page
of 109
Sort By:
Plos One
|
July 30, 2024
Genome wide association study of clinical duration and age at onset of sporadic CJD
Holger Hummerich, Helen Speedy, Tracy Campbell, et al.
Science Immunology
|
August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutations
William Rae, John M Sowerby, Dorit Verhoeven, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2018
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
The Lancet. Digital Health
|
October 27, 2023
A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study
Heather R Jackson, Judith Zandstra, Stephanie Menikou, et al.
Blood
|
November 2, 2022
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, et al.
The Lancet. Oncology
|
October 24, 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Leukemia
|
January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
A A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Blood
|
April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Maria Sirenko, Elsa Bernard, Maria Creignou, et al.
Page
of 109
Search research articles
Search
Showing results (1001-1010 of 1,087) with videos related to
Sort By:
Page
of 109
Plos One
|
July 30, 2024
Genome wide association study of clinical duration and age at onset of sporadic CJD
Holger Hummerich, Helen Speedy, Tracy Campbell, et al.
Science Immunology
|
August 12, 2022
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutations
William Rae, John M Sowerby, Dorit Verhoeven, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2018
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
The Lancet. Digital Health
|
October 27, 2023
A multi-platform approach to identify a blood-based host protein signature for distinguishing between bacterial and viral infections in febrile children (PERFORM): a multi-cohort machine learning study
Heather R Jackson, Judith Zandstra, Stephanie Menikou, et al.
Blood
|
November 2, 2022
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, et al.
The Lancet. Oncology
|
October 24, 2018
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Linda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Leukemia
|
January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
A A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Blood
|
April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Maria Sirenko, Elsa Bernard, Maria Creignou, et al.
Page
of 109